Artio Medical Closes $8.8 Million of Additional Financing
Fairway, KS – March 31, 2020 – Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular and neurovascular markets, announced today it has closed an additional $8.8 million in Series A financing, bringing the total capital raised to date to more than $20 million.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, Founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.” The additional funds will help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market the Solus Gold™ Embolization Device in the US.
“We appreciate the strong support from our new and existing investors,” said F. Nicholas Franano, MD, President and CEO of Artio. “Our team is looking forward to making our innovative products available to physicians and patients.”
About Artio Medical
Artio Medical is a medical device company committed to developing innovative endovascular products for the treatment of peripheral vascular, neurovascular, and structural heart diseases. Artio’s products are designed to provide precision placement, immediate occlusion, and rapid sealing of arteries, veins, saccular aneurysms, and other blood-containing structures. For more information, please visit www.artiomedical.com.
About the EnduraTM Embolization System
Cerebral aneurysms affect about 4% of the global population. There are almost 500,000 deaths worldwide each year caused by brain aneurysms, usually due to rupture and hemorrhagic stroke. Cerebral aneurysm embolization is a minimally invasive procedure that blocks or reduces blood flow into cerebral aneurysms to treat or prevent hemorrhagic stroke. Artio Medical is developing the Endura Embolization System to provide a new option for cerebral aneurysm occlusion. The system offers a unique combination of coils and a balloon designed for placement within the aneurysm sac to provide immediate aneurysm occlusion. The Endura System has three components, a detachable polymer balloon device called the Endura Embolization Accessory Device, Endura Aneurysm Coils, and Endura Balloon Coils. These components are designed to work together to cover the aneurysm neck, frame and fill the aneurysm sac, and provide immediate aneurysm occlusion while reducing the risk of coil prolapse into the parent vessel.
Company Contact:
Jenny Martin
Director of Marketing and Operations
Artio Medical, Inc.
949.278.0870
jmartin@artiomedical.com
Media Contact:
Jessi Swanoski
Sprig Consulting, LLC
218.213.8708
jessi@sprigconsulting.com